Astera Labs (ALAB) Price to Sales (2024 - 2026)

Astera Labs (ALAB) has reported Price to Sales for 3 consecutive years, with 213.55 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 172.71% year-over-year to 213.55; the trailing twelve-month figure through Jun 2026 stood at 69.72 (up 180.92% YoY), and the FY2025 full-year result was 33.21, down 24.3% from the prior year.
• Price to Sales climbed to 213.55 in Q2 2026 per ALAB's latest filing, from 60.88 in the prior quarter.
• Across five years, Price to Sales topped out at 213.55 in Q2 2026 and bottomed at 59.72 in Q1 2024.
• Historically, Price to Sales has averaged 104.23 across 3 years, with a median of 91.47 in 2025.
• The sharpest annual moves came in 2025 and 2026: Price to Sales plunged 36.52% in 2025, then soared 172.71% in 2026.
• Over 3 years, Price to Sales stood at 123.22 in 2024, then slipped by 15.08% to 104.63 in 2025, then jumped by 104.09% to 213.55 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 213.55, 60.88, and 104.63 for Q2 2026, Q1 2026, and Q4 2025 respectively.